Mutations of p53 in the context of UGS-induced bladder cancers from Angola along with sialylated glycans have been suggested as surrogate biomarkers of bladder carcinogenesis associated with S. haematobium infection highlighting links between infection and cancer development52. Here, TP53 is linked to urogenital neoplasm.